Influencing Epigenetic Information with a Hydrolytically Stable Carbocyclic 5-Aza-2'-deoxycytidine. 2019

Thomas M Wildenhof, and Sarah Schiffers, and Franziska R Traube, and Peter Mayer, and Thomas Carell
Department of Chemistry, Ludwig-Maximilians-Universität, Butenandtstrasse 5-13, Munich, Germany.

5-Aza-2'-deoxycytidine (AzadC) is an antimetabolite in clinical use, which reduces the level of the epigenetic modification 5-methyl-2'-deoxycytidine (mdC). AzadC is incorporated into the genome of proliferating cells, where it inhibits DNA methyltransferases (DNMTs), leading to a reduction of mdC. The loss of mdC, which is a transcriptional silencer in the promoter region found upstream of genes, leads to the reactivation of the corresponding gene, including tumor-suppressor genes, which elicits a beneficial effect. The problem associated with AzadC is that the compound is hydrolytically unstable. It decomposes during treatment to a variety of poorly characterized hydrolysis products. After its incorporation into the genome, this hydrolytic instability generates abasic sites. It is consequently difficult to dissect whether the activity of the compound is caused by DNMT inhibition or more generally by DNA lesion formation. We now discovered that a disarmed version of AzadC, in which the ribose oxygen was replaced by a CH2 group, is surprisingly stable under a variety of pH values while keeping activity against the DNMTs.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003841 Deoxycytidine A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE. Cytosine Deoxyribonucleoside,Cytosine Deoxyriboside,Deoxyribonucleoside, Cytosine,Deoxyriboside, Cytosine
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000066450 Mouse Embryonic Stem Cells PLURIPOTENT STEM CELLS derived from the BLASTOCYST INNER CELL MASS of day 3.5 mouse embryos. mESC,Cells, Mouse Embryonic Stem,Mouse Embryonic Stem Cell,Stem Cells, Mouse Embryonic,mESCs
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001372 Aza Compounds Organic chemicals where carbon atoms have been replaced by nitrogen atoms. Compounds, Aza
D015254 DNA Modification Methylases Enzymes that are part of the restriction-modification systems. They are responsible for producing a species-characteristic methylation pattern, on either adenine or cytosine residues, in a specific short base sequence in the host cell's own DNA. This methylated sequence will occur many times in the host-cell DNA and remain intact for the lifetime of the cell. Any DNA from another species which gains entry into a living cell and lacks the characteristic methylation pattern will be recognized by the restriction endonucleases of similar specificity and destroyed by cleavage. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms. DNA Modification Methyltransferases,Modification Methylases,Methylases, DNA Modification,Methylases, Modification,Methyltransferases, DNA Modification,Modification Methylases, DNA,Modification Methyltransferases, DNA
D044127 Epigenesis, Genetic A genetic process by which the adult organism is realized via mechanisms that lead to the restriction in the possible fates of cells, eventually leading to their differentiated state. Mechanisms involved cause heritable changes to cells without changes to DNA sequence such as DNA METHYLATION; HISTONE modification; DNA REPLICATION TIMING; NUCLEOSOME positioning; and heterochromatization which result in selective gene expression or repression. Epigenetic Processes,Epigenetic Process,Epigenetics Processes,Genetic Epigenesis,Process, Epigenetic,Processes, Epigenetic,Processes, Epigenetics

Related Publications

Thomas M Wildenhof, and Sarah Schiffers, and Franziska R Traube, and Peter Mayer, and Thomas Carell
October 2005, Seminars in oncology,
Thomas M Wildenhof, and Sarah Schiffers, and Franziska R Traube, and Peter Mayer, and Thomas Carell
June 2009, Biochemistry. Biokhimiia,
Thomas M Wildenhof, and Sarah Schiffers, and Franziska R Traube, and Peter Mayer, and Thomas Carell
June 2017, Bioscience reports,
Thomas M Wildenhof, and Sarah Schiffers, and Franziska R Traube, and Peter Mayer, and Thomas Carell
July 2005, Seminars in hematology,
Thomas M Wildenhof, and Sarah Schiffers, and Franziska R Traube, and Peter Mayer, and Thomas Carell
May 2008, BMC cancer,
Thomas M Wildenhof, and Sarah Schiffers, and Franziska R Traube, and Peter Mayer, and Thomas Carell
January 2013, Frontiers in oncology,
Thomas M Wildenhof, and Sarah Schiffers, and Franziska R Traube, and Peter Mayer, and Thomas Carell
January 1980, Neoplasma,
Thomas M Wildenhof, and Sarah Schiffers, and Franziska R Traube, and Peter Mayer, and Thomas Carell
September 2011, Leukemia research,
Thomas M Wildenhof, and Sarah Schiffers, and Franziska R Traube, and Peter Mayer, and Thomas Carell
January 2003, Journal of applied toxicology : JAT,
Thomas M Wildenhof, and Sarah Schiffers, and Franziska R Traube, and Peter Mayer, and Thomas Carell
August 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research,
Copied contents to your clipboard!